|
Name |
5-Hydroxy-6-(1-acetoxyethyl)-2,7-dimethoxy-1,4-naphthalenedione
|
Molecular Formula | C16H16O7 | |
IUPAC Name* |
1-(1-hydroxy-3,6-dimethoxy-5,8-dioxonaphthalen-2-yl)ethyl acetate
|
|
SMILES |
CC(C1=C(C=C2C(=C1O)C(=O)C=C(C2=O)OC)OC)OC(=O)C
|
|
InChI |
InChI=1S/C16H16O7/c1-7(23-8(2)17)13-11(21-3)5-9-14(16(13)20)10(18)6-12(22-4)15(9)19/h5-7,20H,1-4H3
|
|
InChIKey |
SNIIQTSBSNAYGY-UHFFFAOYSA-N
|
|
Synonyms |
68594-15-0; 5-Hydroxy-6-(1-acetoxyethyl)-2,7-dimethoxy-1,4-naphthalenedione; 2,7-Dimethoxy-6-(1-acetoxyethyl)juglone; 1-(1-hydroxy-3,6-dimethoxy-5,8-dioxonaphthalen-2-yl)ethyl acetate; (-)-6-[1-(acetyloxy)ethyl]-5-hydroxy-2,7-dimethoxy-1,4-naphthalenedione; CHEMBL2204405; DTXSID701151467; HY-N10200; BS-1516; 6-(1-Acetoxyethyl)2,7-dimethoxyjuglone; CS-0371756; 2,7-dimethoxy-5-hydroxy-6-(1-acetoxyethyl)-1,4-naphthoquinone
|
|
CAS | 68594-15-0 | |
PubChem CID | 15061191 | |
ChEMBL ID | CHEMBL2204405 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 320.29 | ALogp: | 1.9 |
HBD: | 1 | HBA: | 7 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 99.1 | Aromatic Rings: | 2 |
Heavy Atoms: | 23 | QED Weighted: | 0.851 |
Caco-2 Permeability: | -5.083 | MDCK Permeability: | 0.00001810 |
Pgp-inhibitor: | 0.014 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.109 | 20% Bioavailability (F20%): | 0.011 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.02 | Plasma Protein Binding (PPB): | 91.82% |
Volume Distribution (VD): | 0.835 | Fu: | 13.41% |
CYP1A2-inhibitor: | 0.78 | CYP1A2-substrate: | 0.876 |
CYP2C19-inhibitor: | 0.041 | CYP2C19-substrate: | 0.073 |
CYP2C9-inhibitor: | 0.342 | CYP2C9-substrate: | 0.639 |
CYP2D6-inhibitor: | 0.225 | CYP2D6-substrate: | 0.258 |
CYP3A4-inhibitor: | 0.211 | CYP3A4-substrate: | 0.167 |
Clearance (CL): | 5.295 | Half-life (T1/2): | 0.812 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.016 |
Drug-inuced Liver Injury (DILI): | 0.76 | AMES Toxicity: | 0.438 |
Rat Oral Acute Toxicity: | 0.309 | Maximum Recommended Daily Dose: | 0.426 |
Skin Sensitization: | 0.828 | Carcinogencity: | 0.046 |
Eye Corrosion: | 0.014 | Eye Irritation: | 0.919 |
Respiratory Toxicity: | 0.463 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003355 | 0.800 | D0C1SF | 0.313 | ||||
ENC005329 | 0.727 | D09DHY | 0.294 | ||||
ENC005149 | 0.727 | D0N1FS | 0.288 | ||||
ENC005160 | 0.727 | D07ESC | 0.276 | ||||
ENC002318 | 0.623 | D06GCK | 0.275 | ||||
ENC005150 | 0.623 | D02LZB | 0.259 | ||||
ENC005330 | 0.623 | D01XWG | 0.252 | ||||
ENC005529 | 0.481 | D00WVW | 0.250 | ||||
ENC004188 | 0.468 | D09GYT | 0.247 | ||||
ENC005148 | 0.459 | D0F4ZY | 0.243 |